[More than six billions Euro costs due to illness days. Migraine therapy counts].
D018712:Analgesics, Non-Narcotic / Q000008:administration & dosage / Q000627:therapeutic use; D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000008:administration & dosage / Q000627:therapeutic use; D000932:Antiemetics / Q000008:administration & dosage / Q000627:therapeutic use; D001241:Aspirin / Q000008:administration & dosage / Q000627:therapeutic use; D017281:Cost of Illness; D003365:Costs and Cost Analysis; D004294:Domperidone / Q000008:administration & dosage / Q000627:therapeutic use; D018492:Dopamine Antagonists / Q000008:administration & dosage / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D005858:Germany; D006801:Humans; D007052:Ibuprofen / Q000008:administration & dosage / Q000627:therapeutic use; D008787:Metoclopramide / Q000008:administration & dosage / Q000627:therapeutic use; D008881:Migraine Disorders / Q000175:diagnosis / Q000188:drug therapy* / Q000191:economics*; D017366:Serotonin Receptor Agonists / Q000008:administration & dosage / Q000627:therapeutic use; D018582:Sick Leave / Q000191:economics*
D018712:Analgesics, Non-Narcotic; D000894:Anti-Inflammatory Agents, Non-Steroidal; D000932:Antiemetics; D018492:Dopamine Antagonists; D017366:Serotonin Receptor Agonists; D004294:Domperidone; D008787:Metoclopramide; D001241:Aspirin; D007052:Ibuprofen